“Something Must Be Done About Daubert” By Russell L. Parr, CFA, ASA, CLP, RPOP[i] Expert witnesses in patent infringement cases often are the subject of
Category: Research
Occupy IP: New Economy Businesses Clash with Old
It May be Too Much, Too Late for Content Providers Finally Trying to Tame the Internet; a Fresh Approach is Needed [The following appears as
Anti-IP Story Tells Only Part of It
Patent Suits are Declining, Not Increasing A recent Reuters BreakingViews story that ran in The New York Times that says the United States Supreme Court should reverse the
“Patent Failure” Fails to Recognize Danger of Too Much Repair
A Reply to Professors Bessen and Meurer’s Book About the Difficulty of Perfecting the Patent System By Roya Ghafele and Benjamin Gibert The publication of
City of Brotherly Love Ranks High in IP Holders, Advisors
iPlaces: Patents Pave Philadelphia Freeway Often overshadowed in technology and finance by the likes of San Francisco-Silicon Valley, Boston and New York, Philadelphia is right
Rumored Investor Stake Fuels RIM IP Asset Speculation
Icahn Interest May Enhance Patent Value or Inflate It – Patent portfolios are making some investors smarter, others richer and companies confused. They also are
Innovative IP Models Generate Cash, Provide Alternatives
New Patent Businesses are Diverse and Well-Capitalized A wider range of intelligent businesses are achieving higher returns on patents by extracting direct profits or providing
Kearns’ Son Still Fuming Over Wiper Blade Fight
Unreasonably high patent licensing hurdles are a “license to steal” – In messages from Robert Kearns’ son Dennis received this week by IP Insider (now, IP CloseUp), it is
Six Years of Talks Fail in Ford Patent Dispute
Flash(back) of Genius? Ford Motor Company was sued twice in one week by businesses that say it is infringing their hands-free inventions, including the company’s popular SYNC voice-command technology If it looks
Wall Street to Patents: "We Love You, Man"
IP Cash is King Right Now – JP Morgan analyst Paul Coster takes a long look at Acacia Research Corporation (NASDAQ: ACTG), a company that
Reputation Counts for Patent Portfolios, Holders
Patent “Brands” are Serious Business – IP pros and stakeholders share an embarrassing secret: both are generally in the dark when it comes to how patents generate
Pharma Cos Face "Patent Cliff" as Protection Expires
Ten Blockbusters will End in Two Years – An article in Daily Finance says that patents that are expiring on many top-selling drugs will cause pharmaceutical
